Viewing Study NCT01459250


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-02-01 @ 9:35 PM
Study NCT ID: NCT01459250
Status: COMPLETED
Last Update Posted: 2020-12-08
First Post: 2011-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AGO178C, View
None renal impairment, View
None ESRD, View
None pharmacokinetics View